Purpose Symptom progression in Huntington disease (HD) is associated with cognitive decline which may interfere with the self-report of symptoms. Unfortunately, data to support or refute the psychometric reliability of patient-reported outcomes (PROs) as HD progresses are limited. This is problematic given that PROs are increasingly recognized as important measures of efficacy for new treatments. Methods We examined PRO data from the HDQLIFE Measurement System (Speech Difficulties; Swallowing Difficulties; Chorea) in 509 individuals with premanifest, early-stage, or late-stage HD. Clinician-administered assessments of motor functioning (items from the UHDRS) and standardized objective assessments of cognition (Stroop, Symbol Digit Modalities) were also collected. We examined item bias using differential item functioning (DIF) across HD stage (premanifest, early-, late-) and relative to cognitive performance. We also examined the correlations between self-report and clinician ratings. Regression models that considered total cognitive ability were utilized to determine psychometric reliability of the PROs. Results Most PRO items were free from DIF for both staging and cognition. There were modest correlations between PROs and clinician report (ranged from − 0.40 to − 0.60). Modeling analyses indicated that psychometric reliability breaks down with poorer cognition and more progressed disease stage; split-half reliability was compromised (i.e., split-half reliability < 0.80) when scores were < 136 for Chorea, < 109 for Speech Difficulties, and < 179 for Swallowing Difficulties. Conclusions Results indicate that the psychometric reliability of PROs can be compromised as HD symptoms progress and cognition declines. Clinicians should consider PROs in conjunction with other types of assessments when total cognition scores exceed critical thresholds.
Introduction
Huntington disease (HD) is an autosomal dominant neurodegenerative disease that affects approximately 1 in 10,000 individuals [1] [2] [3] [4] . HD is both insidious and progressive. The motor, cognitive, and psychiatric symptoms that are characteristic of HD emerge gradually and worsen progressively [5] with the majority of individuals meeting criteria for HD diagnosis around age 40 (diagnosis is based solely on the presence of clinically significant motor symptoms) [6] . The typical course until death is ~ 15-20 years after clinical diagnosis [7] .
Recently, there has been an increased emphasis on utilizing patient-reported outcomes (PROs), especially those that examine health-related quality of life (HRQOL) (i.e., physical, social, and emotional well-being [8] ) in clinical research and care [9] . To this end, the HDQLIFE measurement system [10] was developed as a PRO appropriate for individuals with HD. HDQLIFE includes 12 generic HRQOL measures of HD (from the Neuro-QoL [11, 12] and PROMIS [13, 14] measurement systems: Anxiety, Depression, Anger, Positive Affect and Well-Being, Emotional and Behavioral Dyscontrol, Physical FunctioningUpper Extremity, Physical Functioning-Lower Extremity, Applied Cognition-Executive Functioning, Applied Cognition-General Concerns, Stigma, Ability to Participate in Social Roles and Activities, and Satisfaction with Social Roles and Activities), as well as five new HD-specific measures (Chorea [15] , Speech Difficulties [16] , Swallowing Difficulties [16] , Concern with Death and Dying [17] , and Meaning and Purpose [17] ). While HDQLIFE is the first comprehensive PRO measurement system that includes both generic and HD-specific aspects of HRQOL, there remain significant concerns that the cognitive decline that is characteristic of HD [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] may preclude the ability to utilize PRO measures in this population.
Unfortunately, there are no data to support or refute the applicability of using PROs throughout all stages of HD. Therefore, the purpose of this study was to determine whether it is appropriate to use PROs when significant cognitive decline is present. Since measurement science dictates that PROs should provide both reliable (i.e., repeatable) and valid (i.e., measure what was intended) information, this study focused on establishing the reliability and validity of PRO measures in individuals across the HD disease spectrum to determine if and during what disease stages these measures meet established measurement science standards for PRO reliability and validity. Optimally, items within the PRO should not exhibit item bias across HD stage or for cognitive performance. Furthermore, PROs should meet minimal criteria for acceptable psychometric reliability (i.e., ≥ 0.70 [31] ) and be related to observer reports of similar constructs. Thus, the overall purpose of these analyses was to determine whether and at what stage cognitive impairment and HD disease progression may limit the utility of PRO measures, as evidenced by low reliability and relatively high error variance.
Methods

Participants
We recruited 506 individuals with HD to participate in this study. Participants were recruited through HD specialty clinics (Los Angeles, CA; Iowa City, IA; Indianapolis, IN; Baltimore, MD; Ann Arbor, MI; Golden Valley, MN; St. Louis, MO; Piscataway, NJ), support groups, and HD-specialized nursing home units, and in conjunction with the PREDICT-HD study [32] . Additional recruitment resources included the National Research Roster for Huntington's Disease, articles/advertisements in HD-specific newsletters and websites, and online medical record data capture systems [33] . Inclusion criteria were a positive gene test and/or a clinical diagnosis of HD, ≥ 18 years of age, able to read and understand English, and cognitive capacity to provide informed consent (confirmed by a standardized assessment [34] 
Measures
For the purposes of this study, we examined data from the HDQLIFE measurement system [10] , as well as several standardized assessments from the Unified Huntington's Disease Rating Scales (UHDRS) [35] . These assessments were part of a larger study protocol designed to evaluate HRQOL in HD; more details about the full study protocol are detailed elsewhere [10] . For the purposes of this paper, we examined the baseline data from this study.
HDQLIFE [10] PROs
Three physical functioning item bank PROs from HDQLIFE were administered to study participants: HDQLIFE Chorea [15] , HDQLIFE Speech Difficulties [16] , and HDQLIFE Swallowing Difficulties [16] . HDQLIFE Chorea includes 34 items that assess the impact that chorea (which comprises irregular, random involuntary movements of varying amplitude affecting the face, trunk, and limbs) has on physical activity, participation, and HRQOL in individuals with HD. HDQLIFE Speech Difficulties include 27 items that examine the impact that perceived difficulties in oral expression, language production, and articulation have on communication and general well-being. HDQLIFE Swallowing Difficulties include 16 items that examine the effect that problems with swallowing (preparatory, oral, and pharyngeal) and choking have on eating and overall well-being. All HDQLIFE PROs are scored on a T metric (M = 50, SD = 10); higher scores indicate worse self-reported physical function.
UHDRS [35] clinician-rated assessments
Four different assessments from the UHDRS were administered to study participants: Total Functional Capacity items [36] , the total motor score (TMS), and two cognitive assessments (The Stroop Color Word Test [37] and symbol digit modalities test [SDMT; 38] ). Total functional capacity (TFC) [36] provides an index of day-to-day functioning; scores range from 0 to 13 with high scores indicating better functional capacity. The TFC was used to determine HD group for manifest participants [38] : sum scores of 7-13 = early-stage HD (stages I-II) and sum scores of 0-6 = late-stage HD (stages III-IV). The TMS provides an index of oculomotor function, dysarthria, chorea, dystonia, gait, and postural stability; higher scores indicate worse motor function. Stroop Color Word Interference [37] provides a measure of psychomotor speed and executive function. There are three different parts to this assessment: Color Naming (which requires participants to name blocks of color [either red, green, or blue] as quickly as they can in 45 s), Word Reading (which requires participants to read as many words as they can [either red, green, or blue] in 45 s), and Color/Word Interference(which requires participants to name the color of ink that a word [red, green or blue] is written in, where the word is written in the wrong color of ink [the word red written in green ink] as quickly as they can in 45 s); higher scores on each of these separate components reflect better cognitive performance. The SDMT [39] provides a measure of speed of processing, psychomotor integration, and working memory; it requires participants to match symbols to numbers according to a provided key. Higher scores reflect better cognitive performance. We also created a Total Cognition Score by summing together scores from the Stroop and SDMT raw scores.
Data analysis
Differential item functioning (DIF) using IRT-scaled scorebased ordinal logistic regression [40] was used to examine item bias both across HD stage (premanifest HD, early-HD, late-HD) and relative to cognitive performance (Stroop Color Naming, Stroop word Reading, Stroop Interference, and SDMT); analyses were conducted using LORDIF freeware [41] . In general, items should not exhibit DIF. Some degree of uniform DIF (i.e., when one group consistently has advantage across all levels of ability) is considered acceptable. Non-uniform DIF (i.e., when group advantage differs across different levels of ability) was used to flag potentially problematic items. For both HD stage, and cognitive performance, we considered DIF to be negligible if p was > 0.01 and non-negligible when p was ≤ 0.01.
Pearson correlations between self-reported motor functioning measures and associated clinician ratings of motor functioning were examined; correlations were examined separately for each HD staging group (premanifest, early-, and late-HD). We expected moderate agreement between self-report and clinician ratings (i.e., r's between 0.40 and 0.60). A pattern of less robust correlations as HD stage progresses would provide an indication that measurement may be breaking down.
Partial correlations between self-reported motor functioning measures and associated clinician ratings of motor functioning that controlled for total cognition scores were also examined; again correlations were examined separately for each HD staging group (premanifest, early-, and late-HD). A pattern of less robust correlations (relative to the correlations that did not control for cognitive performance) between HD groups would provide additional evidence that measurement may be breaking down.
Three separate sets of regression models were used to examine both the error variance and psychometric reliability of the HDQLIFE PROs through the examination of splithalf reliabilities (see Fig. 1 ). The first set of simple linear regression models regressed the second split-half reliability score on the first split-half reliability score for each of the HDQLIFE PROs. For these analyses, we would hypothesize that the majority of the variance should be accounted for (i.e., ≥ 90%). In addition, in these simple regression models, the variance, with regard to both staging and cognition would be held constant, and thus we would expect overall model fit to be less robust that for models where variance is allowed to vary (by either staging: second set of models or cognition: third set of models). Thus, we would expect better model fit for the second set of models, heterogeneous variance regression models, i.e., where the variance is allowed to vary for HD stage for each of the separate HDQLIFE PROs (each model was fit with different variances for each HD stage). Similarly, we would expect a better model fit for the third set of heterogeneous variance models, where the variance is allowed to vary for total cognition scores for each of the HDQLIFE PROs. In addition, for each model, we specified that reliability for split-half reliabilities for each PRO should meet minimal acceptable standards (reliability scores can range from 0.0 to 1.0; 0.70-0.79 = acceptable, 0.80-0.89 = good, and ≥ 0.90 = excellent reliability) [42, 43] .
Results
Participants
A total of 509 participants with premanifest and/or manifest HD participated: 197 individuals had premanifest HD (i.e., a positive gene test [CAG ≥ 36] , but no HD clinical diagnosis), 196 had early-stage HD (sum scores of 7-13 on the TFC), and 116 had later-stage HD (sum scores of 0-6 on the TFC). On average, participants were 49.0 years of age (SD = 13.2), and most were Caucasian (95.5%) and female (58.9%). There were significant group differences for age (this was expected since symptoms are progressive with age), F (2, 506) = 48.35, p < 0.0001, with premanifest participants being significantly younger than early-and late-stage participants, and early-stage participants being significantly younger than the late-stage participants. The three groups did not differ by gender, Χ 
Item bias
Most items were free from item bias with regard to the different cognitive tests and HD staging (Table 1) . For HDQLIFE Chorea, no items consistently exhibited DIF for staging or cognitive variables; when present, DIF was negligible. For HDQLIFE Speech Difficulties, 5 items exhibited DIF for both cognition and staging, but none consistently exhibited non-uniform DIF. For HDQLIFE Swallowing Difficulties, 4 items consistently exhibited DIF for both staging and cognitive variables; but none consistently exhibited non-uniform DIF. Taken together, although there were some items for Speech and Swallowing that exhibited uniform DIF, these items did not exhibit non-uniform DIF and the overall magnitude of DIF was minimal.
Pearson and partial correlations
As hypothesized, correlations by staging group were lower for those individuals with late-stage HD relative to the other two groups and differences between groups were less robust after controlling for cognitive performance (Table 2 ).
Regression models
Estimated split-half reliabilities for the PROs by HD stage (premanifest, early, and late) are provided in Table 3 ; reliability was excellent for premanifest participants, good for early-HD, and acceptable for late-HD. As hypothesized, simple regression models indicated that the majority of the variance (R 2 ) was accounted for when the second split-half reliability score was regressed on the first split-half reliability score (Table 4) . Furthermore, as anticipated, both the models that allowed for heterogeneous variance (for staging and cognition) showed significantly better fit than the simple regression models (Table 5) . These results are shown in Figs. 2, 3, and 4 (which provide graphic representations of the residual data generated for HDQLIFE Chorea, Speech Difficulties, and Swallowing Difficulties, respectively). Specifically, within each figure, overall variability increases both by HD stage (premanifest participant residual scores have less variability than early-HD participants, who have less variability than late-HD participants across the three different PROs), as well as by overall cognition (as total cognition scores decrease, the overall variability increases for residual scores for all three PROs). Critical Uniform positive* cutoff scores (for total cognition) for ensuring minimal acceptable split-half reliability are provided in Table 6 .
Discussion
Although PROs are gaining influence in both the clinical and research areas, questions remain about the reliability of using self-report measures where cognitive decline is present. As such, we examined the psychometric reliability of several PROs in individuals with HD, where cognitive decline is commonly a problem. We sought to determine when it is appropriate to use PROs independently, and when other complementary assessments of functioning and HRQOL are needed. Our findings indicated that with more progressed HD and poorer cognition function, high error variance, and low reliability can negatively affect the psychometric properties of PRO measures. We recommend clinical cutoffs ( Table 6 ) for cognition that can be used to Table 4 Simple regression models that examine the ability for the first split-half reliability score to predict the second split-half reliability score aid the researcher and clinician in interpreting PRO data in individuals with HD. Specifically, findings indicated that most items within the PROs were free from item bias with regard to cognitive and HD disease status (Table 1) . For the different PROs, item bias was negligible for HDQLIFE Chorea, and while there was some evidence for bias for a handful of items on HDQLIFE Speech Difficulties and HDQLIFE Swallowing Difficulties, this bias was not systematic minimizing the overall impact that this bias might have on overall clinical interpretation. Furthermore, as expected, correlations among the PROs and clinician-rated symptoms were less robust with more progressed HD stages, suggesting increased discordance among self-report and clinician report with disease progression. This was further supported by correlations that considered cognitive performance; in these cases, group differences were less robust. Similarly, estimated split-half reliability was less robust with each progressive HD stage, again indicating that measurement reliability is lower within increasing levels of HD symptom burden. Furthermore, when this variability in measurement reliability took either cognitive status and/or HD staging into consideration, there was better model fit indicating that both cognitive status and disease stage impact psychometric reliability of each of the different PROs. Regardless of the combined evidence of decreased psychometric reliability with both increased disease stage and increased cognitive decline, PROs still typically met acceptable standards for reliability (i.e., > 0.70) [31] . While these findings would suggest that PROs may remain appropriate for use in later-stage HD, we offer clinical cutoffs for cognitive scores that can be used to maximize PRO reliability among those with cognitive decline (Table 6) . Fig. 2 Residual plot for HDQLIFE Chorea. This figure provides a scatterplot of the residual scores for the HDQLIFE Chorea measure: variability increases both by HD stage (premanifest participants have less variability in residual scores than early-HD participants, who have less variability than late-HD participants), and overall cognition (as total cognition scores decrease, the overall variability in residual scores increases) Fig. 3 Residual Plot for HDQLIFE Speech Difficulties. This figure provides a scatterplot of the residual scores for the HDQLIFE Speech Difficulties measure: variability increases both by HD stage (premanifest participants have less variability in residual scores than early-HD participants, who have less variability than late-HD participants), and overall cognition (as total cognition scores decrease, the overall variability in residual scores increases) Specifically, the clinical cutoff scores provided in Table 6 can be used to highlight when caution should be utilized in administering PROs in individuals with HD. For example, when using HDQLIFE Chorea to assess the impact that these motor symptoms have on HRQOL in HD, participants with combined cognitive raw scores (Stroop Color Naming raw score + Stroop Word Reading raw score + Stroop Interference raw score + SDMT raw score) of ≥ 77 meet "acceptable" standards for measurement reliability (i.e., ≥ 0.70) and those with combined cognitive raw scores of ≥ 136 meet the psychometric standards for "good" (i.e., ≥ 0.80) overall test reliability [31] . In cases where cognitive scores do not meet critical cutoffs, PRO scores should only be considered in conjunction with other assessments. It should be noted that these cutoff scores are somewhat imprecise, however, and fail to consider the known influences of age and education.
It is also important to note that the recommended cutoffs vary for each of the different PRO measures. For example, while the minimal acceptable total cognitive raw score = 77 for HDQLIFE Chorea, there is no critical cutoff score for HDQLIFE Speech Difficulties (i.e., all participants in our sample exceeded minimal reliability cutoffs regardless of their cognitive status), and the critical cognitive cutoff score for HDQLIFE Swallowing Difficulties = 134. Thus, while the psychometric reliability of the HDQLIFE Speech Difficulties PRO was never in question for those individuals with HD with poor cognitive performance, there was a critical cutoff score for both Chorea and Swallowing Difficulties. In fact, cognitive performance cutoffs were substantially higher for Swallowing Difficulties (i.e., ≥ 134), than it was for HDQLIFE Chorea (i.e., ≥ 77). There are a number of potential explanations for this difference. One possibility is that the cognitive complexity (sentence structure, recall burden, etc.) for each of the different PROs is different. This argument is elucidated using the following HDQLIFE Swallowing Difficulties items: "In the past 7 days, how often did you have trouble finishing your meal because of your difficulty swallowing?" This exemplar item requires the participant to consider each meal that he or she had over the course of the past week, then consider if he/she had difficulty finishing the meal, and if yes, was this because of swallowing or some other reason. One can see how the cognitive complexity of this type of question may be problematic for an individual with cognitive difficulties, especially those that are characterized by retrieval or working memory deficits such as is the case in individuals with HD. As such, the cognitive status required to answer a complex item such as the provided example is likely higher than that of a more simplistic item (i.e., the HDQLIFE Speech Difficulties item: "In the past 7 days, it was difficult to speak clearly"). An alternative explanation is that this difference may be due to the nature of the domain itself, as well as associated change over time (or lack thereof). For example, while the rate of progression Fig. 4 Residual Plot for HDQLIFE Swallowing Difficulties. This figure provides a scatterplot of the residual scores for the HDQLIFE Swallowing Difficulties measure: variability increases both by HD stage (premanifest participants have less variability in residual scores than early-HD participants, who have less variability than late-HD participants), and overall cognition (as total cognition scores decrease, the overall variability in residual scores increases) for swallowing difficulties (as well as speech difficulties) appears to be consistent over the course of the disease, [44, 45] the rate of progression for chorea declines in the more advanced stages [46] [47] [48] [49] . As such, it is also possible that the different cognitive cutoff scores may be explained by the fact that chorea might be less problematic for individuals with more advanced HD. In fact, it seems especially plausible that differences in the rates of progression for these symptom domains, in conjunction with associated anosognosia (especially in more advanced disease), [50] [51] [52] [53] [54] may contribute to the differential performance of these PRO measures. While these results highlight several important findings, it is also important to acknowledge study weaknesses. Although this study engaged participants across the United States, this convenience sample may not accurately represent the broader HD community, especially with regard to gender (as this sample included slightly more females than males), education (our participants were generally more educated than the general populations), and race/ethnicity (rates for race/ethnicity were consistent with established prevalence rates [55] [56] [57] [58] , this sample was primarily Caucasian). In addition, participants were allowed to complete surveys over a 2-week time frame of the in-person (i.e., clinician-rated assessments), which may have contributed to less robust correlations between self-report and clinician-reported functioning.
Regardless of these study limitations, this is the first study that we are aware of that focuses on understanding PRO in a clinical population where both anosognosia [50] [51] [52] [53] [54] and cognitive decline [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] are present. Not surprisingly, results suggested that high error variance and low reliability can negatively affect the psychometric properties of PRO measures, especially in those participants with late-stage HD and cognitive impairments. Nonetheless, psychometric reliability, although less robust among more progressed participants, typically still met established clinical standards of measurement. As such these measures may still provide valuable information about HRQOL, especially from the participant's perspective. Thus, while we would recommend using PROs throughout the HD disease course, these measures should be used in conjunction with either clinicianrated reports or observer ratings with more advanced stage people; the potential discrepancies between patient report and other observer reports can in and of itself provide clinically meaningful information that can help guide treatment recommendations for these individuals.
